Sponsor

Morphic Medical Inc.

Clinical research sponsor

How to interpret these research links

Connected source records

The exact organization name Morphic Medical Inc. appears in 16 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Published trials16
Recruiting shown1
Roles2
SourceClinicalTrials.gov
Advertisement

Clinical trials

16 shown
The RESET System Pivotal Clinical Trial (Protocol Revision H)NCT04101669 · lead sponsor · 2019-09-09
RECRUITING
EndoBarrier® SANS™ in Over-weight or Obese Type 2 Diabetic SubjectsNCT02443753 · lead sponsor · 2015-05-01
TERMINATED
An Open-Label Extension to Protocol 09-1, Efficacy and Safety Study of the EndoBarrier® Gastrointestinal Liner SystemNCT02293720 · lead sponsor · 2015-04-01
WITHDRAWN
Safety and Efficacy of EndoBarrier in Subjects With Type 2 Diabetes Who Are ObeseNCT01728116 · lead sponsor · 2012-12-01
TERMINATED
Registry Observing EndoBarrier® Treatment Outcomes in Subjects With Type 2 Diabetes and/or ObesityNCT03072901 · lead sponsor · 2010-12-01
TERMINATED
Post Marketing Study in Subjects Who Have Type 2 Diabetes Using the EndoBarrier™ Gastrointestinal LinerNCT01114438 · lead sponsor · 2010-10-01
COMPLETED
Study of Obese Subjects Previously Implanted With the EndoBarrier Gastrointestinal LinerNCT01372501 · lead sponsor · 2010-09-01
COMPLETED
Study of EndoBarrier Liner for Treatment of Type 2 Diabetes StudyNCT00986349 · lead sponsor · 2010-06-01
COMPLETED
Safety and Efficacy Study of EndoBarrier in Subjects With Type II Diabetes and ObesityNCT00985114 · lead sponsor · 2009-10-01
COMPLETED
A Pilot Trial of the EndoBarrier™ Flow Restrictor for Glycemic Improvement in Type 2 DiabeticsNCT00973960 · lead sponsor · 2009-09-01
COMPLETED
Study for Pre-Surgical Weight Loss in Type II Diabetes PatientsNCT00791128 · lead sponsor · 2008-10-01
COMPLETED
Study for Short Term Weight Loss in Candidates for Bariatric SurgeryNCT00985491 · lead sponsor · 2008-10-01
COMPLETED
Multi-Center Pre-Bariatric Weight Loss StudyNCT00469391 · lead sponsor · 2007-06-01
COMPLETED
A Study of the GI Sleeve for the Treatment of Type 2 DiabetesNCT02709577 · lead sponsor · 2007-01-01
COMPLETED
A Multicenter Study for Pre-Surgical Weight LossNCT00830440 · lead sponsor · 2007-01-01
COMPLETED
EndoBarrier Register Deutschland-Safety and Efficacy of the Endoscopic Duodenal-Jejunal Bypass SleeveNCT02731859 · collaborator · 2014-01-01
UNKNOWN

Drugs studied in this sponsor's trials

0 mapped RxNorm concepts

These drug records are connected through ClinicalTrials.gov studies listing Morphic Medical Inc. as a sponsor, collaborator or responsible party. Each count is the number of distinct trials containing the mapped drug intervention. This does not establish that the organization manufactures, owns, sells or developed the drug.

No mapped drug interventions are published for this sponsor's trials. This does not mean the studies contain no drug interventions: some registry names have not been mapped to RxNorm.

Sponsor roles

lead sponsor15
collaborator1
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.